Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | PLX-4720 | 1 | uM | 3 | 2500.00 | 2418.67 | 4707.00 | 4493.25 | 1.0476 | 1.1068 |
SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4613.00 | 4493.25 | 1.0267 | 1.0597 |
SK-BR-3 | Nilotinib | 10 | uM | 3 | 2500.00 | 2418.67 | 1993.00 | 4493.25 | 0.4436 | -0.1948 |
SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4508.00 | 4493.25 | 1.0033 | 1.0073 |
SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 1706.00 | 4493.25 | 0.3797 | -0.3234 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4625.00 | 4493.25 | 1.0293 | 1.0657 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4330.00 | 4493.25 | 0.9637 | 0.9189 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4131.00 | 4493.25 | 0.9194 | 0.8204 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4247.00 | 4493.25 | 0.9452 | 0.8777 | |
SK-BR-3 | Etoposide | 1 | uM | 3 | 2500.00 | 2418.67 | 2280.00 | 4493.25 | 0.5074 | -0.0639 |
SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 2500.00 | 2418.67 | 4495.00 | 4493.25 | 1.0004 | 1.0009 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4544.00 | 4493.25 | 1.0113 | 1.0253 | |
SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 2500.00 | 2418.67 | 1863.00 | 4493.25 | 0.4146 | -0.2533 |
SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4632.00 | 4493.25 | 1.0309 | 1.0692 |
SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4664.00 | 4493.25 | 1.0380 | 1.0852 |
SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4708.00 | 4493.25 | 1.0478 | 1.1073 |
SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 4805.00 | 4493.25 | 1.0694 | 1.1559 |
SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 2500.00 | 2418.67 | 4385.00 | 4493.25 | 0.9759 | 0.9462 |
SK-BR-3 | Etoposide | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4223.00 | 4493.25 | 0.9399 | 0.8659 |
SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4562.00 | 4493.25 | 1.0153 | 1.0343 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4799.00 | 4493.25 | 1.0680 | 1.1529 | |
SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 4203.00 | 4493.25 | 0.9354 | 0.8560 |
SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4627.00 | 4493.25 | 1.0298 | 1.0667 |
SK-BR-3 | Nilotinib | 1 | uM | 3 | 2500.00 | 2418.67 | 4698.00 | 4493.25 | 1.0456 | 1.1023 |
SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4698.00 | 4493.25 | 1.0456 | 1.1023 |